MedTrace Logo

Three-month Clinical Evaluation of DSiHy Daily Disposable Silicone Hydrogel Contact Lenses

NCT03859440 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-03-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical performance of two daily disposable silicone hydrogel contact lenses. One of these lenses, the 'test' lens is an investigational product. This means that it has not yet been approved for commercial use and is not available for sale. The other lens (control) is a commercially available contact lens.

The results of this study will be analysed to determine how the 'test' lens compares with the 'control' lens. The control lens has been chosen because it is a market leader and is well tried and tested.

Participants who are in this study will need to have healthy eyes, except for the need to correct their eyesight. Up to 90 people who are aged 20 years or older will be considered for participation in this study. The study is designed to be approximately 3 months long.

Conditions

  • Contact Lenses

Interventions

DEVICE

DSiHy Silicone hydrogel soft contact lens

•Device: DSiHy (test lens) Silicone hydrogel soft contact lens for daily disposable wear.

DEVICE

CE-marked Silicone hydrogel soft contact lens

・Device: Silicone hydrogel soft contact lens CE-marked for daily disposable wear. Other Name : MyDay

Sponsors & Collaborators

  • HOYA Lamphun Ltd

    lead INDUSTRY

Principal Investigators

  • Graeme Young, Dr · Visioncare Research Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2019-10-31
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03859440 on ClinicalTrials.gov